Results 131 to 140 of about 28,908 (220)

Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK/elF2α/ATF4/CHOP pathway in breast cancer. [PDF]

Cell Death Dis, 2021
Li X, Zheng J, Chen S, Meng FD, Ning J, Sun SL.   +5 more
europepmc   +1 more source

ACUTE INTAKE OF A LARGE DOSE OF CARDIAC GLYCOSIDES BY A YOUNG MALE

Проблеми екології та медицини, 2017
One of the most toxic drugs is a group of cardiac glycosides. Having a very narrow spectrum of therapeutic action, cardiac glycosides are able to cause serious intoxication with complications including arrhythmias and conduction disorder, which often ...
L. Savchenko, I. Mormol, P. Husar, N. Reva, O. Borzykh, I. Kaydashev   +5 more
doaj  

Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? [PDF]

, 2001
McMurray, John J.V.
core   +1 more source

Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase. [PDF]

Invest Ophthalmol Vis Sci, 2020
Schmid V, Plössl K, Schmid C, Bernklau S, Weber BHF, Friedrich U.   +5 more
europepmc   +1 more source

Antitumor Activity of the Cardiac Glycoside αlDiginoside by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells. [PDF]

Int J Mol Sci, 2020
Weng JR, Lin WY, Bai LY, Hu JL, Feng CH.
europepmc   +1 more source

Author Correction: Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells. [PDF]

Acta Pharmacol Sin, 2020
Zhu JJ, Zhang XX, Miao YQ, He SF, Tian DM, Yao XS, Tang JS, Gan Y.   +7 more
europepmc   +1 more source

Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19. [PDF]

Cell Biosci
Ha DP, Shin WJ, Liu Z, Doche ME, Lau R, Leli NM, Conn CS, Russo M, Lorenzato A, Koumenis C, Yu M, Mumenthaler SM, Lee AS.   +12 more
europepmc   +1 more source

Inflammatory myocardial disease and toxicity in horses : a recent update [PDF]

, 2012
Decloedt, Annelies, van Loon, Gunther
core  

Update on a brain-penetrant cardiac glycoside that can lower cellular prion protein levels in human and guinea pig paradigms. [PDF]

PLoS One
Eid S, Zhao W, Williams D, Nasser Z, Griffin J, Nagorny P, Schmitt-Ulms G.   +6 more
europepmc   +1 more source

Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial. [PDF]

Front Pharmacol
El-Mahdy NA, Tadros MG, El-Masry TA, Binsaleh AY, Alsubaie N, Alrossies A, Abd Elhamid MI, Osman EY, Shalaby HM, Saif DS.   +9 more
europepmc   +1 more source